Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The diagnostic accuracy of exercise 99mTc-labeled sestamibi and intravenous dipyridamole 201Tl-labeled myocardial tomography is established. The accuracy of dipyridamole stress 99mTc-labeled sestamibi myocardial tomography for the detection of coronary artery disease has not been reported.
Methods and Results
Our purpose was to determine the diagnostic accuracy of same-day, rest-dipyridamole stress 99mTc-labeled sestamibi myocardial single-photon emission computed tomography (SPECT) compared with coronary angiography. Two hundred forty-four patients who were unable to exercise adequately underwent both dipyridamole 99mTc-labeled sestamibi SPECT and coronary angiography within 6 months. Dipyridamole was administered intravenously in a standard dose of 0.56 mg/kg for 4 minutes. Cardiac and noncardiac side effects were recorded. The presence of coronary stenoses of 50% or greater diameter reduction in each of the major coronary arteries was compared with imaging data in corresponding myocardial perfusion beds. The patient population was predominately (98.8%) male with a mean age of 63±9 years (range 33 to 83 years). The majority of patients had stable angina (88%). Eighty-four patients (35%) gave a prior history of myocardial infarction; 44 patients (18%) had a history of congestire heart failure. The principal limitation to exercise stress was peripheral vascular disease in 62 patients (26%). No serious side effects occurred during dipyridamole stress; 14% of patients had chest pain and 8% of patients had 1 mm or greater ST segment depression. Of the 204 patients with documented coronary stenoses, 43 (21%) had single-vessel disease and 161 (79%) had multivessel disease. The sensitivity was 93% (40/43 in patients with single-vessel disease) and 91% (146/161 in patients with multivessel disease). Overall sensitivity was 91%. The specificity was 28% (11/40) in this population with a high prestest probability of coronary artery disease and posttest referral for cardiac catheterization.
99mTc-labeled sestamibi myocardial tomography in conjunction with intravenous dipyridamole stress is a safe and sensitive method for the detection of coronary artery disease. The diagnostic accuracy of dipyridamole stress 99mTc-labeled sestamibi SPECT for the detection of coronary artery disease is similar to that reported for exercise stress 99mTc-labeled sestamibi tomography, making this a suitable alternative for the evaluation of patients who are unable to exercise adequately.
- Maddahi J, Kiat H, Van Train KF, Pirgent F, Friedman J, Garcia E, et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990;66:55E-62E. CrossRef
- Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority, of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 1988;12:25–34.
- Najm YC, Maisey, MN, Clarke SM, Fogelman I, Curry PVL, Sowton E. Exercise myocardial perfusion scintigraphy with technetium-99m methoxy isobutylisonitrile: a comparative study with thallium-201. Int J Cardiol 1990;26:93–102. CrossRef
- Kiat H, Maddahi J, Roy LT, Van Train K, Freidman J, Resser K, et al. Comparison of technetium 99m methoxy isobutylisonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1–11. CrossRef
- Iskandrian AS, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989;64:270–5. CrossRef
- Kahn JK, McGhie I, Akers MS, Sills MN, Faber TL, Kulkami PV, et al. Quantitative rotational tomography with 201Tl and 99mTc-methoxy-isobutyl-isonitrile. Circulation 1989;79:1282–93.
- Maddahi J, Rodrigues E, Berman DS, Kiat H. State-of-the-art myocardial perfusion imaging. Cardiol Clin North Am 1994;12:199–222.
- Rozanski A, Diamond GA, Berman D, Forrester JS, Morris D, Swan HJC. The declining specificity of radionuclide ventriculography. N Engl J Med 1983;309:518–22.
- Mendelsson MA, Spies SM, Spies WG, Abi-Mansour P, Fintel DJ, Usefulness of single-photon emission computed tomography of thallium-201 uptake after dipyridamole infusion for detection of coronary artery disease. Am J Cardiol 1992;69:1150–5. CrossRef
- Stratmann HG, Kennedy HL. Evaluation of coronary artery disease in the patient unable to exercise: alternatives to exercise stress testing. Am Heart J 1984;117:1344–65. CrossRef
- Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990;66:1163–70. CrossRef
- Miller DD, Labovitz AJ. Dipyridamole and adenosine vasodilator stress for myocardial imaging: viva la différence. J Am Coll Cardiol 1994;23:390–2.
- Lam JYT, Chairman BR, Glaenzer M, Byers S, Fite J, Shah Y, et al. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol 1988;11:585–9.
- Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients woth stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647–52. CrossRef
- Freeman GL, Colston JT, Miller DD. Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure. J Nucl Cardiol 1994;1:172–82. CrossRef
- Parodi O, Marcassa C, Casucci R, Sambuceti G, Verna E, Galli M, et al. Accuracy and safety of thechnetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (sestamibi), myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. J Am Coll Cardiol 1991;18:1439–44.
- Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, et al. Correlation of pharmacologic technetium-99m sestamibi myocardial perfusion imaging with post-stenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150–60.
- Lam JYT, Chaitman BR, Glaenzer M, Byers S, Fite J, Shah Y, et al. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol 1988;11:585–9.
- Depasquale EE, Nody AC, DePuey EG, Garcia EV, Pilcher G, Bredlau C, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988;77:316–27.
- Maddahi J, Van Train K, Prignet F, Garcia EV, Friedman J, Ostrzega E, et al. Quantitative single photon emission computed thallium-201 tomography for dection and localization of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689–99. CrossRef
- Van Train KF, Maddahi J, Berman DS, Kiat H, Areeda J, Prigent F, et al. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 1990;31:1168–79.
- Van Train KF, Areeda J, Garcia EV, Cooke D, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress technetium-99m sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494–502.
- DePuey EG, Rozanski A. Using gated technetium-99m sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995;36:952–5.
- Taillefer R, DePuey GE, Udelson J, Beller GA, Latour Y, Reeves F, et al. Comparison of thallium-201 and Tc-99m sestamibi (perfusion and gated SPECT) myocardial perfusion imaging in detection of CAD in women. Circulation 1995;92(suppl):I-129.
- Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol 1990;16:1375–83.
- Lalonde D, Taillefer R, Lambert R, Bisson G, Basile F, Prieto I, et al. Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease. J Nucl Med 1994;35:1245–53.
- Ignaszewski AP, McCormick LX, Heslip PC, McEwan AJ, Humen DP. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 1993;34:2053–61.
- Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease
Journal of Nuclear Cardiology
Volume 4, Issue 1 , pp 18-24
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- single-photon emission computed tomography
- myocardial perfusion
- coronary artery disease
- diagnostic accuracy
- Industry Sectors
- Author Affiliations
- 1. Division of Cardiology, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, Mo.
- 2. John Cochran Veterans Administration Medical Center, St. Louis, Mo.